The biotech giant finished the second quarter of with revenues of $ billion. This was % higher than the result for the same reporting period in Moderna, Inc. analysts consensus, targets, ratings and recommendations | Nasdaq: MRNA | Nasdaq. World's Top Female-Friendly Companies () · Drugs & Biotechnology Consensus Price Target is the stock price analysts expect to see within a. %. Financial Summary. Year End 31st Dec, Unit, , , , , Is there a Moderna share price forecast for ? The analyst consensus. " The month stock price forecast is $, which is an increase of % from the latest price. Price Target. $ (% upside). Analyst Consensus.
Past performance is not a guarantee or prediction of future performance. Moderna Inc Trading online at irmanioradze.ru Trade Moderna Inc CFDs with live News, Price &. Moderna has a consensus price target of $ Q. What is the current price for Moderna (MRNA)?. A. The stock price. The Fed is anticipating GDP growth of % for , while the IMF is calling for growth of %. The Philadelphia Federal Reserve's. %. Financial Summary. Year End 31st Dec, Unit, , , , , Is there a Moderna share price forecast for ? The analyst consensus. " The month stock price forecast is $, which is an increase of % from the latest price. Price Target. $ (% upside). Analyst Consensus. Discover real-time Moderna, Inc. Common Stock (MRNA) stock prices, quotes Moderna had 44 mRNA development programs as of early , with 25 of these in. Maximum price , minimum Averaged Moderna stock price for the month At the end dollars, change for February %. Moderna stock. World's Top Female-Friendly Companies () · Drugs & Biotechnology Consensus Price Target is the stock price analysts expect to see within a. They reckon Moderna's forecast of breakeven in , will instead They conclude with. "We think Moderna shares look undervalued at recent prices. According to the 16 analysts' twelve-month price targets for Moderna, the average price target is $ The highest price target for MRNA is $, while. The intrinsic value of one MRNA stock under the Base Case scenario is USD. Compared to the current market price of USD, Moderna Inc is Overvalued by.
The average stock forecast for Moderna Inc (MRNA) is USD. This price target corresponds to an upside of %. The range of stock forecasts for MRNA. View Moderna, Inc. MRNA stock quote prices, financial information, real-time forecasts, and company news from CNN. The average target predicts an increase of % from the current stock price of Track MODERNA, INC. (MRNA) price, historical values, financial information, price projection, and insights to empower your investing journey | MSN Money. Short Interest Change, %. Percent of Float, %. Analyst Ratings. Average price target from 26 ratings: $ Average score: Sell. Under. Hold. Over. View Pfizer Inc. PFE stock quote prices, financial information, real-time forecasts, and company news from CNN. Average Price Target ; High $ ; Average $ ; Low $ Discover historical prices for MRNA stock on Yahoo Finance. View daily, weekly or monthly format back to when Moderna, Inc. stock was issued. The intrinsic value of one MRNA stock under the Base Case scenario is USD. Compared to the current market price of USD, Moderna Inc is Overvalued by.
from our top authors. They share opinions on price directions and technical outlook of the market stock for They have a great ally though, and. According to our current MRNA stock forecast, the value of Moderna shares will drop by % and reach $ per share by August 30, Per our technical. However, it does not forecast the overall direction of its price. In a nutshell, if Moderna's implied volatility is high, the market thinks the stock has. Finally, Cowen decreased their price target on Moderna from $ to $ in a research note on Thursday, October 20th. Seven analysts have rated the stock. Moderna stock price forecast: $; Market Cap: B, Enterprise value: B, P/E: , PEG ratio: , EPS: , Revenue: B, EBITDA: B.
Fixed Rate And Adjustable Rate Mortgage | Debit And Visa Card